Topic: AmerisourceBergen - Sponsored
With the advent of cell and gene therapies, getting those treatments to the right patients at the right time is more important than ever.
Heralded as the next great chapter in pharmaceutical history, biosimilars are expected to trim healthcare costs while giving patients more access.
Guiding drug manufacturers through the tumultuous waters of healthcare policy has never been more important.
The role of distributors like AmerisourceBergen, is to ensure patients can get access to therapies, no matter where they present.